Challenges of hepatocellular cancer diagnosing in computed tomography. Lecture and demonstration of observations
https://doi.org/10.16931/1995-5464.2020239-48
Abstract
Hepatocellular carcinoma has a special place among the malignant tumors, because the computed tomography or magnetic resonance picture allows to accurately disease diagnose without a biopsy. This circumstance calls for thorough assessment of the classical and atypical variants of changes detected during radiologic imaging. This paper illustrates various versions of the CT-scan picture of hepatocellular cancer. The various variants of a CT scan of hepatocellular carcinoma are illustrated in this publication.
About the Authors
E. V. Rozengauz
Granov Russian Scientific Center of Radiology and Surgical Technologies;
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
Russian Federation
Evgeny V. Rozengauz – Doct. of Sci. (Med.), Chief Researcher of the Department of Radiology, Granov Russian Scientific Center of Radiology and Surgical Technologies, Professor of the Department of Radiology and Radiation Therapy, North-Western State Medical University named after I. I. Mechnikov
70, Leningradskaya str., Pesochny, 197758, S.-Petersburg,
41, Kirochnaya str., St. Petersburg, 191050
A. G. Karakhanova
Petrov National Medical Research Center of Oncology
Russian Federation
Russian Federation
Anna G. Karakhanova – Radiologist of the Department of X-ray Computed Tomography
68, Leningradskaya str., Pesochny, St. Petersburg, 197758
References
1. Choi J.Y., Lee J.M., Sirlin C.B. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology. 2014; 272 (3): 635–654. https://doi.org/10.1148/radiol.14132361
2. Karmazanovsky G.G. The role of MDCT and MRI in the diagnosis of focal liver diseases. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2019; 24 (4): 91–110. https://doi.org/10.16931/1995-5464.2019491-110 (In Russian)
3. Roberts L.R., Sirlin C.B., Zaiem F., Almasri J., Prokop L.J., Heimbach J.K., Murad M.H., Mohammed K. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 2018; 67 (1): 401–421. https://doi.org/10.1002/hep.29487
4. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., Christensen E., Pagliaro L., Colombo M., Rodés J. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma.Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol. 2001; 35 (3): 421–430. https://doi.org/10.1016/s0168-8278(01)00130-1
5. Lee J.H., Lee J.M., Kim S.J., Baek J.H., Yun S.H., Kim K.W., Han J.K., Choi B.I. Enhancement patterns of hepatocellular carcinomas on multiphasic multidetector row CT: comparison with pathological differentiation. Br. J. Radiol. 2012; 85 (1017): e573–e583. https://doi.org/10.1259/bjr/86767895
6. Tumanova U.N., Yachina N.I., Karmazanovsky G.G., Shchegolev A.I. Сomputed tomography diagnostic criteria of hepatocellular carcinoma with varying degree of differentiation in the liver unaffected by cirrhosis. Diagnostic and interventional radiology. 2015; 9 (1); 27–33. (In Russian)
7. Rozengauz E.V., Karakhanova A.G., Nesterov D.V. Contrast enhancement patterns of hepatocellular carcinoma with portal vein thrombosis. Medical Visualization. 2019; 23 (4): 68–75. https://doi.org/10.24835/1607-0763-2019-4-68-75 (In Russian)
8. Lafitte M., Laurent V., Soyer P., Ayav A., Balaj C., Petit I., Hossu G. MDCT features of hepatocellular carcinoma (HCC) in non-cirrhotic liver. Diagn. Interv. Imaging. 2016; 97 (3): 355–360. http://dx.doi.org/10.1016/j.diii.2015.09.007.
9. Basaran С., Karcaaltincaba M., Akata D., Karabulut N., Akinci D., Ozmen M., Akhan O. Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR. Am. J. Roentgenol. 2005; 184: 1103–1110. https://doi.org/0361–803X/05/1844–1103
10. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 2012; 56 (4): 908–943. https://doi.org/10.1016/j.jhep.2011.12.001.
11. Luca A., Caruso S., Milazzo M., Mamone G., Marrone G., Miraglia R., Maruzzelli L., Carollo V., Minervini M.I., Vizzini G., Gruttadauria S., Gridelli B. Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. Eur. Radiol. 2010; 20 (4): 898–907. https://doi.org/10.1007/s00330-009-1622-0
12. Kutami R., Nakashima Y., Nakashima O., Shiota K., Kojiro M. Pathomorphologic study on the mechanism of fat change in small hepatocellular carcinoma in humans. J. Hepatol. 2000; 33 (2): 282–289. https://doi.org/10.1016/s0168-8278(00)80369-4
13. Umar N.K., Badshah M.B., Sandrasegaran K., Ghabril M., Agarwal S., Tann M., Lacerda M., Kwo P.Y. Thepresens of portal vein thrombosis alters the classic enhancement associated with diagnosis of hepatocellular carcinoma. Dig. Dis. Sci. 2015; 60 (7): 2196–2200. https://doi.org/10.1007/s10620-015-3587-y.
14. Kneuertz P.J., Demirjian A., Firoozmand A., CoronaVillalobos C., Bhagat N., Herman J., Cameron A., Gurakar A., Cosgrove D., Choti M.A., Geschwind J.F., Kamel I.R., Pawlik T.M. Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann. Surg. Oncol. 2012; 19 (9): 2897–2907. https://doi.org/10.1245/s10434-012-2336-0
Review
For citations:
Rozengauz E.V., Karakhanova A.G. Challenges of hepatocellular cancer diagnosing in computed tomography. Lecture and demonstration of observations. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2020;25(2):39-48. (In Russ.) https://doi.org/10.16931/1995-5464.2020239-48
Views:
881
Email this article 